Additional in vivo experiments revealed that asprosin augmented glucose intolerance, insulin resistance, endoplasmic reticulum (ER) stress, as well as circulation of pro-inflammatory cytokines (monocyte chemoattractant protein-1, MCP-1; IL-6; and TNFα) in mice [24]. The gene discussed is IL6; the disease is Insulin resistance.